These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 2467732)

  • 1. Expression of ras oncogene p21 protein in relation to regional spread of human breast carcinomas.
    Czerniak B; Chen R; Tuziak T; Markiewski M; Kram A; Gorczyca W; Deitch D; Herz F; Koss LG
    Cancer; 1989 May; 63(10):2008-13. PubMed ID: 2467732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunocytochemical demonstration and significance of p21 ras family oncogene product in benign and malignant breast disease.
    Candlish W; Kerr IB; Simpson HW
    J Pathol; 1986 Nov; 150(3):163-7. PubMed ID: 3027290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence of enhancement of the ras oncogene protein product (p21) in a spectrum of human tumors.
    De Biasi F; Del Sal G; Hand PH
    Int J Cancer; 1989 Mar; 43(3):431-5. PubMed ID: 2784420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical detection of ras oncogene p21 product in benign and malignant mammary tissue in man.
    Ghosh AK; Moore M; Harris M
    J Clin Pathol; 1986 Apr; 39(4):428-34. PubMed ID: 3009557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical study of oncogene product ras p21, c-myc and growth factor EGF in breast carcinomas.
    Mizukami Y; Nonomura A; Noguchi M; Taniya T; Koyasaki N; Saito Y; Hashimoto T; Matsubara F; Yanaihara N
    Anticancer Res; 1991; 11(4):1485-94. PubMed ID: 1660689
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced expression of c-Ha-ras p21 in human stomach adenocarcinomas defined by immunoassays using monoclonal antibodies and in situ hybridization.
    Ohuchi N; Hand PH; Merlo G; Fujita J; Mariani-Costantini R; Thor A; Nose M; Callahan R; Schlom J
    Cancer Res; 1987 Mar; 47(5):1413-20. PubMed ID: 2434216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of ras p21 in mammary and extramammary Paget's disease.
    Mori O; Hachisuka H; Nakano S; Sasai Y; Shiku H
    Arch Pathol Lab Med; 1990 Aug; 114(8):858-61. PubMed ID: 1695839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of the 21,000 molecular weight ras protein in a spectrum of benign and malignant human mammary tissues.
    Ohuchi N; Thor A; Page DL; Hand PH; Halter SA; Schlom J
    Cancer Res; 1986 May; 46(5):2511-9. PubMed ID: 3084069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Elevated ras oncogene expression correlates with lymph node metastases in breast cancer patients.
    Lundy J; Grimson R; Mishriki Y; Chao S; Oravez S; Fromowitz F; Viola MV
    J Clin Oncol; 1986 Sep; 4(9):1321-5. PubMed ID: 3528401
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ras oncogene and the acquisition of metastasizing properties by rectal adenocarcinoma.
    Michelassi F; Erroi F; Roncella M; Block GE
    Dis Colon Rectum; 1989 Aug; 32(8):665-8. PubMed ID: 2666052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Expression of ras oncogene p21 in relation to prognostic factors of human breast cancer].
    Nishimura R; Nagao K; Miyayama H; Matsuda M; Baba K; Matsuoka Y; Ueno Y; Yamashita H; Nomura K; Ichiguchi O
    Gan To Kagaku Ryoho; 1991 Oct; 18(13):2271-5. PubMed ID: 1656890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Quantitation of Harvey ras p21 enhanced expression in human breast and colon carcinomas.
    Hand PH; Vilasi V; Thor A; Ohuchi N; Schlom J
    J Natl Cancer Inst; 1987 Jul; 79(1):59-65. PubMed ID: 3298786
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of ras oncogene p21 protein in early gastric carcinoma and adjacent gastric epithelia.
    Czerniak B; Herz F; Gorczyca W; Koss LG
    Cancer; 1989 Oct; 64(7):1467-73. PubMed ID: 2550123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ras p21 expression in the progression of breast cancer.
    Fromowitz FB; Viola MV; Chao S; Oravez S; Mishriki Y; Finkel G; Grimson R; Lundy J
    Hum Pathol; 1987 Dec; 18(12):1268-75. PubMed ID: 3315956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of ras oncogene p21 in prostate cancer.
    Viola MV; Fromowitz F; Oravez S; Deb S; Finkel G; Lundy J; Hand P; Thor A; Schlom J
    N Engl J Med; 1986 Jan; 314(3):133-7. PubMed ID: 2417118
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ras Oncogene p21 expression is increased in premalignant lesions and high grade bladder carcinoma.
    Viola MV; Fromowitz F; Oravez S; Deb S; Schlom J
    J Exp Med; 1985 May; 161(5):1213-8. PubMed ID: 3886828
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of ras gene expression in stomach cancer by anti-ras p21 monoclonal antibodies.
    Yoshida K; Hamatani K; Koide H; Abe Y; Ikeda H; Tsuchiyama H; Nakayama E; Shiku H
    Cancer Detect Prev; 1988; 12(1-6):369-76. PubMed ID: 3052835
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Ha-ras oncogene product in rat gastrointestinal carcinomas induced by chemical carcinogens.
    Yasui W; Sumiyoshi H; Yamamoto T; Oda N; Kameda T; Tanaka T; Tahara E
    Acta Pathol Jpn; 1987 Nov; 37(11):1731-41. PubMed ID: 3501927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ras p21 immunostaining in early stage squamous cervical carcinoma: relationship with lymph nodal involvement and 72 kDa-metalloproteinase index.
    Garzetti GG; Ciavattini A; Lucarini G; Goteri G; Nictolis MD; Romanini C; Biagini G
    Anticancer Res; 1998; 18(1B):609-13. PubMed ID: 9568185
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p21 ras protein expression in benign and malignant human breast.
    Walker RA; Wilkinson N
    J Pathol; 1988 Oct; 156(2):147-53. PubMed ID: 3058913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.